Inhibition of Histone Demethylase JMJD1A Improves Anti-Angiogenic Therapy and Reduces Tumor-Associated Macrophages

Findings highlight a strategy to target cancer cells resistant to hypoxia and nutrient starvation as an approach to heighten sensitivity to antiangiogenic drugs and to reduce risks of drug resistance and tumor recurrence.